BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:TRB-061 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of TRB-061\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06934252-1504@assetmemo.bio
DTSTAMP:20261121T005832Z
DTSTART;VALUE=DATE:20270902
DTEND;VALUE=DATE:20270903
SUMMARY:TRB-061: Phase 1 readout est. (NCT06934252)
DESCRIPTION:TRB-061\, phase 1\, Atopic Dermatitis.\nStudy: Phase 1a/1b Stud
 y of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis\nEs
 timated primary completion: 2 September 2027. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/trb-061#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT06934252
URL:https://assetmemo.bio/drug/trb-061#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
